CEO Charlene Son Rigby Talks Drug Development and the Rare Research Roadmap

May 24, 2023

Charlene Son Rigby, CEO of Global Genes, talks about rare drug development, how patient advocates can contribute and drive the process, and the journey on the rare research roadmap.